Shaping Future
Biologics

With 15+ years of GMP experience and 45+ CMC development programs completed, Glycothera stands for science that endures — precise, transparent, and built on clarity and consistency.

years in GMP environments
0 +
CMC development programs completed
0 +
biologics supported through EMA/FDA approval
0 +
molecules in clinical development
0 +

Experience that builds trust

We understand what biologics need to advance from idea to approval — structured processes, transparent data, and decisions grounded in long-standing GMP practice.

Across Julich and Hanover, our teams combine scientific depth with practical CMC expertise, making each step predictable, aligned, and well-grounded.

We shape the future of biologics through scientific excellence

Glycothera is a specialized development partner — focused, reliable, and built on science. With a proven record across multiple molecule classes and more than six biologics supported through EMA/FDA approval, we deliver clarity, precision, and results that stand up to regulatory review.

From CMC development to regulatory confidence

Our expertise spans the full CMC arc — from cell line and process development to analytical characterization and GMP-ready testing. Services can be engaged as integrated packages or as flexible modules tailored to your molecule and development stage.

Cell Line Development

From DNA to dossier-ready cell lines — stable, productive, and aligned with regulatory expectations.

Process Development

Media and feed screening, scale-up, and parameter definition — consistent, controlled, and ready for transfer.

Analytics & GMP Testing

160+ analytical methods and long-standing GMP experience — clear, compliant, and reliable from molecular insight to GMP-ready testing.

Proof, not promise

More than 45 projects completed, more than six biologics supported through EMA/FDA approval, and over 15 molecules in clinical development.

Our work stands up to audits, agencies, and time — reflected in a track record that spans antibodies (IgG1, IgG2, IgG4, and bispecific formats), Fc-fusion proteins, glycohormones, cytokines, enzymes, and clotting factor, across host systems including CHO, SP2/0, and NS0.

Inside Glycothera

Curious minds, clear goals, open dialogue, and shared responsibility — that’s what defines Glycothera. Explore scientific updates, GMP insights, upcoming conferences, and opportunities to join our teams in Julich and Hanover.

Let’s start the conversation

Planning a new project or looking for a development partner you can trust? Tell us about your molecule, your timeline, or your analytical needs — we’ll take it from there.

Icon blue Glycothera CDMO - Shaping future biologics Bird icon blue